TABLE 1.
Drug | MIC breakpoint(s)a | Results for N. pseudobrasiliensis isolate(s) from: |
Result for N. brasiliensis isolates from reference 4d | |||
---|---|---|---|---|---|---|
This case report |
Reference |
|||||
MIC (interpretation) | Inhibition zoneb (interpretation) | 25 (% with susceptibility)c | 15d | |||
Amikacin | ≤8, ≥16 | ND | 24 (S) | S (100) | S | S |
Amoxicillin-clavulanic acid | ≤8/4, ≥32/16 | 2 (S) | 12 (R) | R (81) | ND | S |
Ceftriaxone | ≤8, ≥64 | ND | 20 (S) | S (69) | R | S |
Ciprofloxacin | ≤1, ≥4 | 0.125 (S) | 33 (S) | S (95) | S | R |
Clarithromycin | ≤2, ≥8 | 0.125 (S) | ND | S (91) | S | R |
Imipenem | ≤4, ≥16 | >32 (R) | 8 (R) | R (>90) | R | S |
Linezolid | ≤8 | ND | 35 (S) | ND | S | S |
Minocycline | ≤1, ≥8 | ND | 27 (S) | ND | R | S |
Sulfamethoxazole | ≤32, ≥64 | ND | 6 (S) | S (94) | R | S |
Tobramycin | ≤4, ≥16 | ND | 32 (S) | ND | ND | ND |
MIC resistance breakpoints are those from the NCCLS (16): the first value indicates the susceptibility breakpoint, and the second value indicates the resistance breakpoint.
Inhibition zones, measured in millimeters, were determined by the Mueller-Hinton agar disk diffusion method.
The percentage of susceptible or resistant strains as determined by the Etest method.
MICs were determined by the Etest method.